{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Cao L"],"funding":["345 Talent Project of Shengjing Hospital of China Medical University","National Natural Science Foundation of China","Yong Elite Scientist Sponsorship Program by Cast","Tianjin Health Research Program","Beijing Chao-Yang Hospital Golden Seeds Foundation"],"pagination":["101"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10919055"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["22(1)"],"pubmed_abstract":["Background
Non-alcoholic fatty liver disease (NAFLD) and metabolic-associated fatty liver disease (MAFLD) shares common pathophysiological mechanisms with type 2 diabetes, making them significant risk factors for type 2 diabetes. The present study aimed to assess the epidemiological feature of type 2 diabetes in patients with NAFLD or MAFLD at global levels.Methods
Published studies were searched for terms that included type 2 diabetes, and NAFLD or MAFLD using PubMed, EMBASE, MEDLINE, and Web of Science databases from their inception to December 2022. The pooled global and regional prevalence and incidence density of type 2 diabetes in patients with NAFLD or MAFLD were evaluated using random-effects meta-analysis. Potential sources of heterogeneity were investigated using "],"journal":["BMC medicine"],"pubmed_title":["Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis."],"pmcid":["PMC10919055"],"funding_grant_id":["82003456","M0294","CYJZ202102","2020QNRC001","82103811","TJWJ2022QN043"],"pubmed_authors":["Cao L","Liu H","Xia Y","Jiang J","Shi M","Lu Y","Lv Y","Chen L","Dai W","Zhou Y","Zhao Y","Liu W","An Y"],"additional_accession":[]},"is_claimable":false,"name":"Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.","description":"Background
Non-alcoholic fatty liver disease (NAFLD) and metabolic-associated fatty liver disease (MAFLD) shares common pathophysiological mechanisms with type 2 diabetes, making them significant risk factors for type 2 diabetes. The present study aimed to assess the epidemiological feature of type 2 diabetes in patients with NAFLD or MAFLD at global levels.Methods
Published studies were searched for terms that included type 2 diabetes, and NAFLD or MAFLD using PubMed, EMBASE, MEDLINE, and Web of Science databases from their inception to December 2022. The pooled global and regional prevalence and incidence density of type 2 diabetes in patients with NAFLD or MAFLD were evaluated using random-effects meta-analysis. Potential sources of heterogeneity were investigated using ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Mar","modification":"2025-04-04T12:34:48.737Z","creation":"2025-04-04T12:34:48.737Z"},"accession":"S-EPMC10919055","cross_references":{"pubmed":["38448943"],"doi":["10.1186/s12916-024-03315-0"]}}